AMBARELLA INC (AMBA)

KYG037AX1015 - Common Stock

74.755  -1.45 (-1.9%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMBA. AMBA was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. While AMBA has a great health rating, there are worries on its profitability. AMBA is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

AMBA had negative earnings in the past year.
In the past year AMBA had a positive cash flow from operations.
AMBA had negative earnings in each of the past 5 years.
AMBA had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -23.48%, AMBA is not doing good in the industry: 81.31% of the companies in the same industry are doing better.
AMBA has a worse Return On Equity (-28.41%) than 78.50% of its industry peers.
Industry RankSector Rank
ROA -23.48%
ROE -28.41%
ROIC N/A
ROA(3y)-12.99%
ROA(5y)-11.58%
ROE(3y)-15.29%
ROE(5y)-13.69%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMBA has a Gross Margin of 60.52%. This is amongst the best in the industry. AMBA outperforms 85.05% of its industry peers.
AMBA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-0.07%

More info and screens

7

2. Health

2.1 Basic Checks

AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMBA has been increased compared to 1 year ago.
The number of shares outstanding for AMBA has been increased compared to 5 years ago.
There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 15.93 indicates that AMBA is not in any danger for bankruptcy at the moment.
AMBA has a Altman-Z score of 15.93. This is amongst the best in the industry. AMBA outperforms 84.11% of its industry peers.
AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.93
ROIC/WACCN/A
WACC14.64%

2.3 Liquidity

A Current Ratio of 2.84 indicates that AMBA has no problem at all paying its short term obligations.
AMBA has a Current ratio (2.84) which is in line with its industry peers.
A Quick Ratio of 2.50 indicates that AMBA has no problem at all paying its short term obligations.
AMBA has a Quick ratio (2.50) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 2.5

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AMBA have decreased strongly by -48.57% in the last year.
AMBA shows a decrease in Revenue. In the last year, the revenue decreased by -2.18%.
Measured over the past years, AMBA shows a decrease in Revenue. The Revenue has been decreasing by -0.12% on average per year.
EPS 1Y (TTM)-48.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%139.29%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y0.52%
Revenue growth 5Y-0.12%
Sales Q2Q%63.36%

3.2 Future

Based on estimates for the next years, AMBA will show a very strong growth in Earnings Per Share. The EPS will grow by 28.42% on average per year.
Based on estimates for the next years, AMBA will show a very strong growth in Revenue. The Revenue will grow by 20.15% on average per year.
EPS Next Y62.94%
EPS Next 2Y34.32%
EPS Next 3Y33.29%
EPS Next 5Y28.42%
Revenue Next Year21.51%
Revenue Next 2Y18.64%
Revenue Next 3Y18.84%
Revenue Next 5Y20.15%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMBA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMBA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AMBA's earnings are expected to grow with 33.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.32%
EPS Next 3Y33.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMBA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMBARELLA INC

NASDAQ:AMBA (1/10/2025, 1:25:22 PM)

74.755

-1.45 (-1.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-26 2024-11-26/amc
Earnings (Next)N/A N/A
Inst Owners84.92%
Inst Owner Change0%
Ins Owners2.93%
Ins Owner Change-2.42%
Market Cap3.12B
Analysts75.24
Price Target91.34 (22.19%)
Short Float %3.63%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)121.65%
Min EPS beat(2)33.67%
Max EPS beat(2)209.63%
EPS beat(4)4
Avg EPS beat(4)72.48%
Min EPS beat(4)18.46%
Max EPS beat(4)209.63%
EPS beat(8)8
Avg EPS beat(8)54.51%
EPS beat(12)12
Avg EPS beat(12)39.88%
EPS beat(16)16
Avg EPS beat(16)39.64%
Revenue beat(2)2
Avg Revenue beat(2)1.57%
Min Revenue beat(2)0.61%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)2.54%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)2
Avg Revenue beat(12)-1.02%
Revenue beat(16)6
Avg Revenue beat(16)-0.29%
PT rev (1m)1.55%
PT rev (3m)21.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)34.84%
EPS NY rev (1m)39.48%
EPS NY rev (3m)42.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.29%
Revenue NY rev (1m)4.63%
Revenue NY rev (3m)4.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.35
P/FCF N/A
P/OCF 712.69
P/B 5.62
P/tB 15.15
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.1
OCFY0.14%
SpS6.05
BVpS13.29
TBVpS4.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.48%
ROE -28.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.52%
FCFM N/A
ROA(3y)-12.99%
ROA(5y)-11.58%
ROE(3y)-15.29%
ROE(5y)-13.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-0.07%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.69%
Cap/Sales 3.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 2.5
Altman-Z 15.93
F-Score4
WACC14.64%
ROIC/WACCN/A
Cap/Depr(3y)64.48%
Cap/Depr(5y)49.96%
Cap/Sales(3y)4.23%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%139.29%
EPS Next Y62.94%
EPS Next 2Y34.32%
EPS Next 3Y33.29%
EPS Next 5Y28.42%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y0.52%
Revenue growth 5Y-0.12%
Sales Q2Q%63.36%
Revenue Next Year21.51%
Revenue Next 2Y18.64%
Revenue Next 3Y18.84%
Revenue Next 5Y20.15%
EBIT growth 1Y-1.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.38%
EBIT Next 3Y34.22%
EBIT Next 5Y32.4%
FCF growth 1Y-108.7%
FCF growth 3Y-35.2%
FCF growth 5Y-20.07%
OCF growth 1Y-92.66%
OCF growth 3Y-14.84%
OCF growth 5Y-4.93%